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Understanding the functional complexity of protein
interactions requires mapping biomolecular com-
plexes within the cellular environment over biologi-
cally relevant time scales. Herein, we describe
a set of reversible multicolored heteroprotein com-
plementation fragments based on various firefly
and click beetle luciferases that utilize the same
substrate, D-luciferin. Luciferase heteroprotein frag-
ment complementation systems enabled dual-color
quantification of two discrete pairs of interacting
proteins simultaneously or two distinct proteins
interacting with a third shared protein in live cells.
Using real-timeanalysisof clickbeetlegreenandclick
beetle red luciferase heteroprotein fragment comple-
mentationapplied tob-TrCP,anE3-ligasecommon to
the regulationofbothb-cateninand IkBa, GSK3bwas
identified as a candidate kinase regulating IkBa
processing. These dual-color protein interaction
switches may enable directed dynamic analysis of
a variety of protein interactions in living cells.
INTRODUCTION
Protein-protein interactions are fundamental to living systems,
mediating many cellular functions, including signal transduction,
cell cycle progression, apoptosis, and metabolic control. Tradi-
tional techniques in biochemistry for isolation and purification
of protein complexes tend to select for only the most robust of
interactions, whereas weak and transient protein interactions
may escape detection (Sali et al., 2003). Furthermore, many
protein interactions arise from cell-to-cell-mediated signaling in
a tissue-restricted manner that cannot be investigated fully
with in vitro systems and, thus, there is considerable interest in
imaging signal transduction and protein-protein interactions
noninvasively in their normal physiological context within living
organisms (reviewed in Villalobos et al., 2007). Previous strate-
gies have employed transcriptional modification, activated
signal transduction, or modification of enzymatic activity to
generate readily observable biological or physical reporter read-
outs (Luker et al., 2003; Toby and Golemis, 2001). Of the many
strategies for detecting protein interactions in cellulo, several1018 Chemistry & Biology 17, 1018–1029, September 24, 2010 ª201features of the protein fragment complementation assay (PCA)
render it attractive for monitoring protein interactions in general,
and in live cells in particular (Galarneau et al., 2002; Hu and
Kerppola, 2003; Luker and Piwnica-Worms, 2004; Luker et al.,
2004; Michnick et al., 2007; Ozawa and Umezawa, 2001;
Remy and Michnick, 1999; Remy and Michnick, 2004; Remy
et al., 1999; Villalobos et al., 2007; von Degenfeld et al., 2007;
Wehrman et al., 2002). Protein fragment complementation
assays conventionally depend on division of a monomeric
enzyme into two separate inactive components, which are fused
to interacting proteins of interest (Michnick et al., 2007; Villalobos
et al., 2007). Upon association of the interacting proteins, the
reporter fragments reassemble thereby generating reporter
activity. Thus, a fundamental advantage of the PCA strategy is
that the hybrid proteins rapidly and directly reconstitute an
enzymatic reporter activity within the cell, offering the potential
benefit of real-time analysis and enhanced sensitivity for detect-
ing weakly interacting proteins. In principle, protein interactions
may be detected in any subcellular compartment, and assembly
of protein complexes with a broad range of affinities may
be monitored. The innovation of luciferase protein fragment
complementation has further allowed for rapid, readily observ-
able signals that can be interrogated in real-time in living animals
in vivo (Villalobos et al., 2007).
Several luciferase protein fragment complementation variants
have been designed on the basis of firefly (P. pyralis),Renilla, and
Gaussia luciferases (Kaihara et al., 2003; Kim et al., 2004, 2007;
Luker and Piwnica-Worms, 2004; Luker et al., 2004; Paulmuru-
gan and Gambhir, 2003, 2005; Remy andMichnick, 2006; Stefan
et al., 2007). As with the intact luciferases, the primary differ-
ences between firefly and Renilla/Gaussia PCA reporters are
the cognate substrates, spectral properties, and quality of emis-
sion (Villalobos et al., 2007; Wilson and Hastings, 1998). Lucif-
erase PCA reporters are useful for real-time imaging of inducible
and reversible interactions within cells or animals and can also
be efficiently utilized in high-throughput systems with a high
degree of sensitivity for protein interaction kinetics. A particularly
favorable firefly luciferase (FLuc) PCA system was initially identi-
fied using an incremental truncation library of large N- and
C-terminal luciferase sequences, and optimal fragments were
found to contain a common overlap sequence (residues 398–
416 of firefly luciferase) (Luker et al., 2004). This reporter system
has been shown to be effective in monitoring protein interactions
in lysates, in live cells, and in living animals with low background
and minimal effect on the interacting proteins of interest (Luker
et al., 2004; Villalobos et al., 2007; Porter et al., 2008).0 Elsevier Ltd All rights reserved
Figure 1. Characterization of Various
Luciferase PCA Reporter Pairs
(A) The basic design of all luciferase PCA reporter
constructs is shown. All references to Luc-N and
Luc-C include fusion to the proteins FRB and
FKBP, respectively, unless otherwise stated. The
overlap sequence found on both N and C termini
are exactly the same on all click beetle luciferase
fragments. Firefly luciferase fragments contain
a homologous overlap region. The Gly-Ser linker
region (black line) is the same for all constructs.
(B) Photon flux in the presence or absence of
rapamycin from all possible iterations of luciferase
PCA reporter pairs expressed in HEK293T
cells. D-luciferin PCA signals were normalized
for transfection efficiency using coelenterazine to
capture Renilla luciferase expression. Firefly
N-terminus (FLuc-N) only produced photon output
when combined with firefly C terminus (FLuc-C).
Click beetle green and red N-termini (CBG-N
and CBR-N, respectively) were active with any
C-terminal fragment, but only marginally with
FLuc-C. The inset shows photon flux of rapamy-
cin-treated cells in log scale to better illustrate
values of heterologous protein fragment comple-
mentation activities.
(C) CBG-N + CBG-C fragments exhibited the best
fold-induction and total photon output of all
possible combinations, while CBR-N + CBG-C
also showed improvement over our previous firefly
luciferase PCA reporter.
(D) The color of emission was primarily determined by the N- terminus in all combinations. The red/green ratio of photon flux in the presence of rapamycin is
calculated as light output from the 590 nm long pass filter divided by the 500–570 nm band pass filter. Higher values correspond to enhanced red output. Error
bars represent ± SEM (n = 4 each). See also Figures S1 and S2.
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Multicolor Click Beetle Luciferase ComplementationTo further explore cellular and biochemical mechanisms of
macromolecular assemblies, we have now developed advanced
constructs derived from D-luciferin-based click beetle green
(CBG) and click beetle red (CBR) luciferases (Pyrophorus
plagiophthalamus). Because secondary structure mapping indi-
cated a significant degree of conserved topology, especially
within a region assigned to the overlapping fragments of our
original firefly luciferase PCA system (Luker et al., 2004), we
hypothesized that the firefly luciferase PCA system could
provide a template for optimal bisection sites of any D-lucif-
erin-based enzyme into functional complementation fragments,
including CBR and CBG. This strategy was then employed to
develop a plethora of novel luciferase PCA pairs, comprising
both homologous and heterologous combinations of various
firefly and click beetle luciferase fragments. Selected luciferase
PCA reporters showed increased photon output and fold-induc-
ibility, as well as the ability to stably emit spectrally distinguish-
able colors, thereby allowing simultaneous quantification of
multiple protein interactions within the same live cell in real-
time using a single bioluminescence substrate.
RESULTS
Development of Color Variations of Luciferase PCA
Reporters
To further develop efficient protein fragment complementation
pairs with useful spectral emission characteristics, CBG and
CBR were chosen because of their use of the same substrate,Chemistry & Biology 17, 1018–102D-luciferin. Although firefly luciferase and click beetle luciferases
only retain approximately 48% amino acid homology, secondary
structure predictions were remarkably similar (see Figure S1
available online). Click beetle luciferases exhibit a large separa-
tion in spectral emission with CBR emitting at lmax = 615 nm
and CBG emitting at lmax = 540 nm. These luciferases also
show little color sensitivity to pH and temperature changes
as opposed to firefly luciferase, in which the maximal emission
color can vary by as much as 40 nm under different reaction
conditions.
Using Clustal V protein domain mapping strategies, fragments
were identified within the click beetle proteins that corresponded
to residues 2–416 and 398–550 of our previously published firefly
luciferase PCA constructs (Luker et al., 2004). These novel PCA
constructs, comprising 2–413 and 395–542 of the click beetle
luciferases, contained an overlap region consisting of 19 amino
acid residues (395–413) present on each click beetle luciferase
fragment.
The rapamycin-binding domain of human mTOR (residues
2024–2113; FRB) and human FK506-binding protein-12 (FKBP)
provided a well-characterized macromolecular interaction plat-
form to validate these new protein fragment complementation
pairs (Chen et al., 1995; Luker et al., 2004). The N-termini frag-
ments of all luciferase PCA constructs were each fused to a flex-
ible G-S linker and the C terminus of FRB, whereas the C-termini
fragments of all constructs were each fused to a flexible G-S
linker and the N terminus of FKBP (Figure 1A). Using HEK293T
cells, protein interactions interrogated by luciferase protein9, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 1019
Figure 2. Biochemical Specificity of Luciferase PCA
A S2035I mutation in FRB (D) that prevented FRB binding to the FKBP:rapamycin complex was introduced into the Luc-N fusion fragment of all reporter
constructs. Each column represents cells that were batch cotransfected with PCA reporters to ensure equal light output and cotransfected with RLuc to docu-
ment equal plating and transfection efficiency during the experiment (data not shown).
(A) Image of HEK293T cells in a 96-well plate. The top 4 rows were treated with 100 nM rapamycin for 6 hr, while the bottom rows were treated with vehicle.
(B) Photon flux of treated versus untreated cells. Inset shows fold-induction of treated over untreated cells.
(C) Western blot using a novel anti-click beetle luciferase (CB) primary antibody shows high avidity binding to intact click beetle luciferases and significant binding
to each click beetle luciferase fusion fragment. FRB-Luc-N and Luc-C-FKBP fusion fragments havemolecular weights of approximately 30 kD and 60 kD, respec-
tively. There is no cross-reactivity to any firefly luciferase protein or fragment.
(D) Western blot (anti-CB) of cell extracts from the experiment shown in panels A and B shows comparable expression of both wild-type CB and DCB fusion
fragments.
(E) Western blots (anti-FRB, top panel; anti-FKBP, middle panel) of cell extracts from identical experiments show comparable expression of all wild-type
and D fusion fragments. Bioluminescence of cotransfected Renilla luciferase confirms comparable levels of transfection efficiency and total cell viability following
treatment with rapamycin (bottom panel). Error bars represent ± SEM (n = 4 each).
Chemistry & Biology
Multicolor Click Beetle Luciferase Complementationfragment complementation were analyzed by live cell biolumi-
nescence imaging.
The optimal luciferase pairs based on total photon flux and
fold-induction by rapamycin (100 nM) utilized the C-terminal
fragment of CBG99 (CBG-C) and the N-terminal fragment of
CBG99 (CBG-N) (Figure 1B, C; Figure S2). Using the FRB-
FKBP protein interaction system to drive productive CBG-C
and CBG-N complementation and comparing the output to our
original firefly luciferase pair, 100 nM rapamycin induced a
5-fold enhancement in total photon flux and a greater than
3-fold enhanced inducibility of CBG over firefly luciferase in live
cells. When combining the CBR N terminus (CBR-N) with
CBG-C, photon flux was comparable to that of our original firefly
luciferase PCA pair, but fold-inducibility more than doubled. The
dominant emission color for all fragment pairs tracked with the
identity of the N terminus (Figure 1D), as might be predicted1020 Chemistry & Biology 17, 1018–1029, September 24, 2010 ª201from the crystal structure showing inclusion of the major D-lucif-
erin reaction center within this fragment (Conti et al., 1996). All
unpaired fragments, when expressed alone, yielded no detect-
able emissions (data not shown), demonstrating the lack of
nonspecific bioluminescence with this system.
Specificity of Complementation
To further demonstrate the specificity of the system, we replaced
wild-type FRBwithDFRB in the luciferase PCA systems (referred
to as DCBG-N, DCBR-N, and DFLuc-N). The DFRB protein
contains a S2035I mutation, which is known to effectively abro-
gate binding of the FKBP:rapamycin complex to FRB (Chen
et al., 1995), thus acting as a negative control. Figure 2A shows
HEK293T cells that were equally transfected with wild-type-N or
D-N fusions plus homologous C fusion PCA pairs along with
intact Renilla luciferase to act as a transfection control. With all0 Elsevier Ltd All rights reserved
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Multicolor Click Beetle Luciferase Complementationfusion pairs, upon treatment with rapamycin for 6 hr, D-N
exhibited no detectable induction, whereas wild-type N fusion
constructs consistently exhibited 20–75-fold induced signal
(Figure 2B).
Although the optimal response was again attributed to the
CBG-N/CBG-C PCA pair (Figure 2B), because both overall
photon output and fold-inducibilty could be a function of the
expression levels of the various fusion fragments (Villalobos
et al., 2007), it was necessary to confirm equal protein content.
First, to facilitate direct determination of protein expression
levels of all homologous and heterologous click beetle luciferase
pairs without antigen bias, we generated a novel polyclonal anti-
body raised against the common overlap sequence of all click
beetle fragments (anti-CB) (Supplemental Experimental Proce-
dures). Control western blots, performed with the intent to char-
acterize our new polyclonal anti-CB antibody, validated the
detection of all click beetle luciferase fragments and intact
proteins (Figure 2C). The N-terminal fusion fragments migrated
at 60 kD, whereas the C-terminal fusion fragments migrated
at 30 kD, and as expected, anti-CB antibody did not recognize
firefly luciferase. Then, lysates of cells used in bioluminescence
assays expressing wild-type-N and D-N click beetle luciferase
fusion pairs were analyzed (Figure 2D), confirming that all CB
fusion proteins were indeed expressed equally. Furthermore,
anti-FRB and anti-FKBP immunoblotting also confirmed that
wild-type-N and D-N (60 kD) as well as C-terminal (30 kD)
fusion pairs of both CB and FLuc were expressed at comparable
levels (Figure 2E). Finally, imaging cotransfected Renilla lucif-
erase with coelenterazine confirmed comparable levels of
transfection efficiency and total cell viability within each set of
luciferase pairs following treatment with rapamycin (Figure 2E).
Thus, we concluded that the nonproductive interactions of D-N
fusion fragments as well as the enhanced activity of the CBG
fusion pair could not be attributed to significant differences in
protein expression levels.
Quantitation of Rapamycin Induction
and Complementation Reversibility
In live HEK293T cells, homologous and heterologous luciferase
PCA fusions with FRB and FKBP were analyzed following a
6-hr incubation with rapamycin and competitively inhibited with
FK506, each over a range of concentrations. Each complemen-
tation pair was individually curve fitted and apparent Kd values
were calculated (Figure 3A). Interestingly, individual Kd values
and the mean apparent Kd value (0.25 ± 0.05 nM), irrespective
of the composition of the paired luciferases, spectral character-
istics, total photon flux, or fold-inducibility, matched previously
reported Kd values for rapamycin (0.2 nM) (Bierer et al., 1990),
suggesting that expression of the various luciferase PCA fusions
in cells had no appreciable impact on the equilibrium state of the
interacting proteins, in this case, FRB-FKBP. In some cases,
there was greater than a 100-fold difference in total photon flux
(e.g., CBG-N + CBG-C versus CBR-N + FLuc-C), but no signifi-
cant difference in the apparent Kd (Kd, 0.24 nM versus 0.23 nM,
respectively). Furthermore, the individual apparent Ki values for
competitive inhibition by FK506 with all the different luciferase
PCA pairs were remarkably close when tested in the presence
of 10 nM rapamycin (Figure 3B). FK506 displacement curves
yielded a mean apparent Ki value (1.6 ± 0.9 nM), comparableChemistry & Biology 17, 1018–102to values previously reported in the literature (0.4 nM) (Bierer
et al., 1990). Importantly, because affinities of macromolecular
interactions are dominated by dissociation rates, the surprising
precision of these quantitative pharmacological titration curves
from live cells (apparent Kd and Ki values) strongly suggested
that the various homologous and heterologous complementa-
tion pairs, regardless of their overall photon output and
spectral properties, represented reversible systems. Further-
more, because these luciferase PCA fusion pairs with FRB-
FKBP reported apparent affinities highly comparable to purified
FRB-FKBP protein systems (Bierer et al., 1990), this implied that
the overall free energies of association/dissociation of these
luciferase fragments were, as desired, effectively near zero.
Although equilibrium analysis in live cells was promising, to
directly demonstrate reversible kinetics of the CBG-N + CBG-C
PCA pair, we performed FK506 displacement experiments
following rapamycin pretreatment while imaging live cells contin-
uously in real time. HEK293T cells were transfected with
plasmids encoding CBG-N and CBG-C PCA fusions and first
treated with rapamycin (10 nM) to induce FRB-FKBP interac-
tions (Figure 3C). Luciferase activity increased within minutes
of rapamycin induction and continued to drift upward. As
expected, the DCBG-N fusion paired with the CBG-C fusion
showed no inducibility when monitored continuously by live
cell real-time imaging (Figure 3C). At 2.5 hr after induction,
FK506 (10 mMfinal concentration) or vehicle (DMSO) were added
to the same media, and cells were sequentially imaged in real
time. Over this longer time course, a brisk loss of biolumines-
cence occurred only with FK506, consistent with competitive
FK506-mediated disruption of rapamycin-induced FRB-FKBP
interactions and, importantly, expectations for reversible kinetics
in live cells. In DMSO-treated cells, bioluminescence signal
continually drifted higher over the time course of the experiment.
Furthermore, when the translation inhibitor cycloheximide
(100 mM) was added to cells that had previously been induced
with rapamycin, luciferase activity remained stable for up to
8 hr (Figure S3), suggesting that the upward drift in signal with
vehicle was due to additional synthesis of new protein. However,
upon addition of FK506 to the rapamycin- and cycloheximide-
pretreated cells, an identical rate of signal loss was observed
as in the absence of cycloheximide (Figure S3). Thus, the loss
of PCA signal could not be attributed to resynthesis and turnover
of new noninteracting fusion proteins, but favored a model
whereby the existing pool of interacting partners was reversibly
dissociating in the presence of FK506. Note that the observed
time constants of the changes in bioluminescence signal from
live cells in these kinetic experiments were limited by the
membrane permeabilities of both rapamycin and FK506, which
are known to be somewhat low (Inoue et al., 2005), and not
necessarily by inherently slow association/dissociation rates
of the PCA fusion proteins within the cytosol. With these com-
pounds, live cell kinetic analysis cannot be directly compared
to live cell equilibrium analysis. Additional control experiments
showed that luciferase PCA reporters were not affected by the
D-luciferin concentration (Figure S4).
To further demonstrate reversible kinetics of our CBG frag-
ments in a temporally faster system independent of rapamycin
permeabilty, both the CBG N- and C-termini fragments were
fused to C termini of EGFR to monitor ligand-induced EGFR9, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 1021
Figure 3. Titration of Rapamycin Induction and FK506 Inhibition of FRB-FKBP Complex Formation by Luciferase Heteroprotein and Homo-
protein PCA
(A) HEK293T cells were incubated in increasing concentrations of rapamycin and photon output determined. Each curve was individually fitted to yield the calcu-
lated Kd values as indicated; the solid line denotes a curve fit of CBG-N and CBG-C. The mean Kd was 0.25 ± 0.05 nM.
(B) Cells were incubated in the presence of 10 nM rapamycin and increasing concentrations of the inhibitor FK506. Each curve was individually fitted to yield the
calculated Ki values as indicated; the solid line denotes a curve fit of CBG-N and CBG-C. The mean Ki was 1.6 ± 0.9 nM.
(C) Reversibility of the CBG-N and CBG-C PCA system. HEK293T cells were transfected with plasmids encoding CBG-C and either CBG-N (C,B), or DCBG-N
(:,6). First, cells were treated with rapamycin (10 nM;C,:) to induce FRB-FKBP interactions or vehicle and imaged sequentially for 150 min. Then, FK506
(10 mM final concentration;B,6) or vehicle were added to the wells and cells imaged sequentially for an additional 325 min. Error bars represent propagated
SEM. See also Figures S3 and S4.
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Multicolor Click Beetle Luciferase Complementationprotein conformation changes (Yang et al., 2009). CHO TetOn
cells were cotransfected with plasmids expressing the EGFR-
CBG PCA fusion pairs and treated with vehicle or EGF ligand
to induce receptor activation. With live cell imaging before
ligand, a steady signal was observed, consistent with the pres-
ence of preexisting EGFR dimers in close proximity within the
plasma membrane. The addition of EGF resulted in a rapid
biphasic signal response, characterized by an immediate drop
in luciferase activity within the first 15–30 s after EGF addition,
followed by a recovery of signal over the subsequent 20 min
(Figure 4; Figure S5). The initial signal loss correlated highly
with known EGFR autophosphorylation events during the first
15–30 s after ligand binding, asymmetric movement of the cyto-
solic C-termini tails of EGFR dimers, and activation of tyrosine
kinase activity as previously reported (Yang et al., 2009). Our
data were consistent with adoption of a constrained conforma-1022 Chemistry & Biology 17, 1018–1029, September 24, 2010 ª201tion by EGFR after autophosphorylation, which prevented
complementation. The subsequent recovery in luciferase PCA
activity corresponded temporally to the known MAPK-mediated
phosphorylation of Thr-669, which places the relaxed C-termini
tails once again in close proximity, leading to desensitization of
the receptor (Yang et al., 2009). As further proof-of-principle,
addition of the MAPK inhibitor U0126 (10 mM final concentration)
resulted in a blunted recovery of luciferasePCAactivity (Figure 4),
consistent with the requirement forMAPK-dependent conforma-
tional changes to induce postactivation rearrangements of the
cytoplamic domain of EGFR. Note that the known ligand-
induced internalization of EGFR and trafficking to endosomal/
lysosomal compartments occurs on a slower time scale, begin-
ning 10–12 min after addition of ligand (Huang et al., 2006;
Kesarwala et al., 2009), when compared to these protein
conformation changes. Thus, sensing the rapid ligand-induced0 Elsevier Ltd All rights reserved
Figure 4. Luciferase PCA Reversibility Assessed Using CBG
Complementation Fragments Fused to the C Terminus of EGFR
CHO TetON cells in 96-well plates were transfected for 24 hr with plasmids
expressing the EGFR-CBG PCA reporters. This was followed by serum starva-
tion for 3 hr prior to imaging to ensure responsiveness to EGF stimulation. Cells
were preincubated for 20 min in the absence (untreated) or presence of either
vehicle (DMSO; (C) or 10 mM U0126 (B) for thermal equilibration. Cells were
then imaged sequentially every 15 s for 10 min to establish a baseline signal,
treated with 25 nM recombinant mouse EGF to initiate activation of EGFR,
and again imaged sequentially for 20 min. Photonic signals from untreated
wells (not shown) were subtracted from EGF-treated wells to isolate EGF-
induced signal changes (D). See Figure S5 for raw photonic data with error
bars. Each data point represents the mean of 8 replicate wells.
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provided evidence for the rapid reversibility of the CBG lucif-
erase PCA system.
Imaging a Two-Color PCA Protein Interaction Switch
in Live Cells
Color separation using a bioluminescence spectral deconvolu-
tion algorithm enables accurate quantification of multi-colored
luciferase reporters (blue versus green versus red) within the
same region of interest (Gammon et al., 2006). As validation,
deconvolution analysis readily separated rapamycin-induced
FRB-FKBP interactions tagged with CBR-N/CBG-C (red) from
those tagged with CBG-N/CBG-C (green) within the same
HEK293T cells (Figure S6). In effect, this demonstrated the quan-
titative imaging of a red/green protein interaction switch in live
cells.
To directly demonstrate use of our interaction switch to inter-
rogate a node within a cellular protein network, we examined in
detail two signaling cascades regulated by the ubiquitin-protea-
some pathway, the central mediator of proteolysis (Deshaies,
1999). Signaling through several important regulators of
transcription, such as b-catenin (b-cat), a key activator of Wnt
signaling (Aberle et al., 1997), and IkBa, an inhibitor of nuclear
factor kB (NFkB) (Karin and Ben-Neriah, 2000), depends on
regulated proteolysis for mediation of downstream transcrip-
tional activation. Phosphorylation of key Ser/Thr residues ofChemistry & Biology 17, 1018–102each of these proteins renders them substrates for rapid polyu-
biquitination by b-TrCP, an E3-ligase common to both pathways
(Fuchs et al., 2004). In the resting state, b-cat interacts continu-
ously with b-TrCP (Hart et al., 1999; Kitagawa et al., 1999)
because of binding induced by site-specific phosphorylation of
b-cat by GSK3b (Siegfried et al., 1992). As a result, low levels
of b-cat are maintained in the cytosol and downstream Wnt
targets are suppressed. Conversely, in an unstimulated state,
IkBa resides in a cytoplasmic complex with NFkB (Ghosh and
Karin, 2002; Karin et al., 2002; Li and Verma, 2002). Upon stim-
ulation with canonical upstream receptor ligands, such as tumor
necrosis factor (TNFa), IkBa is phosphorylated on Ser-32 and
Ser-36, subsequently engaged by b-TrCP, polyubiquitinated,
and rapidly degraded, leading to release and nuclear transloca-
tion of free NFkB for activation of target genes. Thus, b-TrCP
represents a common interaction node in two salient signaling
cascades, providing opportunity to characterize novel modes
of cross-talk between these two pathways in real time.
Therefore, we generated a PCA color switch using CBG-N
fused to the C terminus of b-cat, CBR-N fused to the C terminus
of IkBa, and CBG-C fused to the N terminus of b-TrCP, the
common partner (Figure 5A). HEK293T cells were cotransfected
with all three fusion constructs and, after 48 hr, live cell imaging
was performed every 3 min following addition of TNFa alone,
the GSK3b inhibitor SB-216763 (Frame and Cohen, 2001)
alone, both TNFa and SB-216763, or vehicle (DMSO). Red and
green photon fluxes were monitored in rapid succession, decon-
voluted, and presented as fold-initial, fold-untreated photon
flux (Figure 5B; nonnormalized data are also presented in
Figure S7). Upon stimulation with TNFa, IkBa and b-TrCP fusions
exhibited an increase in red photon flux corresponding to the
anticipated ligand-induced increase in IkBa/b-TrCP interactions,
whereas b-cat and b-TrCP fusions showed no substantial
change in basal green photon flux as expected. However,
although the addition of the GSK3b inhibitor (SB-216763;
50 mM) attenuated basal b-cat/b-TrCP interactions, as would
be predicted, both basal and TNFa-induced IkBa/b-TrCP inter-
actions were similarly and unexpectedly inhibited. As deconvo-
lution controls, HEK293T cells were either cotransfected with
IkBa (red) and b-TrCP PCA fusions (Figure 5C) or separately
with b-cat (green) and b-TrCP PCA fusions (Figure 5D), and
imaged identically. Herein, red and green photon fluxes could
be monitored separately, again yielding the same results as cells
cotransfected with all three fusion reporters (Figure 5B). Control
experiments also showed that SB-216763 had no effect on the
PCA luciferase enzyme activity per se (data not shown).
To independently validate this unanticipated interaction, the
effect of GSK3b inhibition was assessed with an NFkB-
dependent transcriptional reporter, wherein NFkB binding to
kB response elements drives FLuc expression (Gross and Piwn-
ica-Worms, 2005). Although robust transcriptional stimulation
was confirmed upon TNFa treatment, the effect was dramatically
attenuated when TNFa treatment was combined with SB216763
(Figure 6A), thus corroborating our finding that GSK3b activity
was important for NFkB pathway activation. Furthermore,
western blot analysis indicated both the lack of gross overex-
pression of PCA fusion proteins compared to endogenous
protein levels of b-cat, b-TrCP, and IkBa (Figure 6B), as well as
the lack of drug-induced protein degradation, providing direct9, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 1023
Figure 5. Imaging a Two-Color Protein Interaction Switch in HEK293T Cells
(A) b-TrCP fused to CBG-C interacted with IkBa or b-cat fused to CBR-N and CBG-N, respectively, to generate either red light (IkBa) or green light (b-cat).
The effects of TNFa and/or SB-216763 (a GSK3b inhibitor) on processing of IkBa and b-cat, which in turn would modulate interactions with b-TrCP, were
characterized.
(B) Cells were cotransfected with plasmids encoding IkBa-CBR-N (red lines), b-cat-CBG-N (green lines), and CBG-C-b-TrCP for 48 hr, and then imaged in rapid
succession with open, green, and red filters at the times indicated immediately following addition of 20 ng/ml TNFa (squares), 50 mMSB-216763 (triangles), TNFa
plus SB-216763 (diamonds), or vehicle (circles). Photon flux images were subsequently deconvoluted and shown as fold-initial, fold-untreated. Small time
shifts are evident after normalization of the data due to the sequential nature of photon acquisition with the different filter sets. Error bars represent propagated
SEM (n = 4, each). Five independent experiments showed identical trends.
(C) In separate wells, cells were transfected with only IkBa-CBR-N and CBG-C-b-TrCP (red lines) and imaged with an open filter following addition of the same
compounds.
(D) In separate wells, cells were transfected with only b-cat-CBG-N and CBG-C-b-TrCP (green lines) and imaged with an open filter following addition of the same
compounds. See also Figures S6, S7, and S8.
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Multicolor Click Beetle Luciferase Complementationevidence that the sensitivity of the bioluminescence technique
did not require artifactual overexpression of reporter fusions
for analysis.
In support of the physiological significance of this finding,
protein databases revealed that IkBa (NCBI; NP 065390)
contains two S/T-X-X-X-S/T(p) motifs, the canonical GSK3b
substrate sequence (Frame and Cohen, 2001), at residues
IkBa(32-36) and IkBa(164-168). Interestingly, upon TNFa activa-
tion of the pathway, Ser-32 and Ser-36 are known targets for
inhibitor of kB kinase (IKK)–mediated phosphorylation of IkBa,
marking IkBa for b-TrCP-mediated polyubiquitination and
degradation. Mechanistically, phosphorylation of Ser-36 would
concurrently establish a primed GSK3b motif, raising the possi-
bility of synergistic regulation of IkBa degradation by both IKK
and GSK3b, a novel level of regulation not previously character-
ized. To begin to test this model, we modified a previously pub-
lished transcriptionally coupled IkBa-FLuc fusion reporter (Moss
et al., 2008) to generate Ala mutations at Ser-32, Ser-36, or both
in IkBa. We then characterized the dynamic processing of the1024 Chemistry & Biology 17, 1018–1029, September 24, 2010 ª201IkBa mutants compared to wild-type IkBa by real-time biolumi-
nescence imaging of HepG2 cells transiently transfected with
the reporter constructs. Upon treatment with TNFa, loss of signal
from the canonical TNFa-induced degradation of IkBa was
observed with the wild-type IkBa-FLuc reporter (Figure 6C).
However, the S32A and S36A mutants, both singly and
combined, completely abrogated ligand-induced signal loss,
consistent with the model. Although the detailed contributions
of IKK and GSK3b remain to be resolved, these observations
further supported the PCA color switch data that identified
GSK3b as a novel candidate kinase regulating IkBa processing.
DISCUSSION
Protein fragment complementation offers a straightforward,
potentially quantitative approach to monitor protein interactions
in living cells and organisms (Michnick et al., 2007). Other
common strategies, such as two-hybrid transactivation (Chien
et al., 1991) and canonical designs of the split ubiquitin system0 Elsevier Ltd All rights reserved
Figure 6. Validation of GSK3b-Mediated Regulation
(A) Cells were transfected with an pNFkB/FLuc reporter plasmid for 48 hr and imaged pre- and 2 hr posttreatment with vehicle, TNFa, SB-216763 or TNFa
together with SB-216763. Photon flux values are represented as mean fold-initial ± SEM (n = 3 per treatment condition).
(B) For comparison of endogenous and fusion protein levels, western blot analysis was performed on HEK293T cells co-transfected with plasmids encoding
either b-cat-CBG-N and CBG-C-b-TrCP, IkBa-CBR-N and CBG-C-b-TrCP, or b-cat-CBG-N, IkBa-CBR-N and CBG-C-b-TrCP together, as indicated. Cells
were treated with either vehicle or GSK3b inhibitor (SB216763) plus TNFa prior to processing. Bands for both endogenous (lower band) and fusion (upper
band) proteins can be seen in the top panels in each lane: (1) b-cat and b-cat-CBG-N visualized with anti-b-cat Ab, (2) b-TrCP and CBG-C-b-TrCP visualized
with anti-b-TrCP Ab, and (3) IkBa and IkBa-CBR-N visualized with anti-IkBa Ab; bands for actin loading controls are in the lower panels.
(C) For analysis of IkBa processing, HepG2 cells were transiently transfected with pkB5-IkBa-FLuc plasmids (wild-type, S32A, S36A, or S32/36A), and treated
with TNFa (20 ng/mL) or vehicle. Photon flux data over time are presented as fold-initial, fold-untreated (mean ± SEM when larger than the symbol; n = 3 inde-
pendent experiments each performed in triplicate wells).
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Multicolor Click Beetle Luciferase Complementation(Johnsson and Varshavsky, 1994; Stagljar et al., 1998), require
transcription and translation of the reporter protein in response
to stimuli before generating an active signal. A substantial delay
from the moment when target protein interaction occurs to
detection of a positive reporter signal limits their use as true
temporal readouts of protein interactions. Furthermore, lucif-
erase PCA systems allow excitation-free imaging of these
reversible protein interaction systems in live cells and animals
(Luker et al., 2004; Villalobos et al., 2007). The temporal resolu-
tion of luciferase PCA systems are amenable to accurate kinetic
analysis, providing the capacity to monitor medium term
changes in protein interactions, even those regulated by intracel-
lular trafficking, protein degradation, and posttranslational
modifications. Herein, the development of newmulticolored het-
eroprotein fragment complementation systems may allow for
more stringent analysis and deconvolution of complex protein
interaction schemes in real time within living cells. Additionally,
development of the CBG luciferase PCA fragments introduces
a new, reversible, and highly effective protein complementation
system for the measurement of single protein interaction pairs
with high signal-to-noise ratios. Further characterization of steric
limitations and distance requirements between each protein
fragment may serve to additionally clarify the optimal utility of
these fragments.Chemistry & Biology 17, 1018–102Because of the importance of reversibility in assessing
dynamic processes and associations in cellulo, we have em-
ployed several strategies to understand reversibility within the
context of these CBR/CBG luciferase PCA pairs. First, under
equilibrium conditions in live cells, the Kd for FRB-FKBP
interactions and the Ki for FK506 were faithfully reproduced
when compared to literature values. Because reversible rate
equations are fundamental to the derivation of Kd and Ki values,
experimentally titrating accurate values implied reversibility for
our luciferase PCA systems (Michnick et al., 2007). Furthermore,
because our original PCA fragments were discovered by a cell-
based screen of an incremental truncation library and validated
in live mammalian cells (Luker et al., 2004), the fragments were
required to survive the proteasome. Because intracellular chap-
erones bind unfolded proteins for targeted degradation in the
proteasome (Kubota, 2009), we favor a modification of the
canonical PCA model wherein our luciferase fragments reside
in a partially folded transition state (rather than unfolded) inde-
pendent of driver protein-protein interactions, which would
protect resting fragments from the proteasome. A partially folded
transition state also would be consistent with a low activation
energy and low DG contribution from the complementation frag-
ments to the overall binding energy of the protein interaction
system under study, thereby enabling readout of accurate Kd9, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 1025
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iments exploring FK506-induced FRB-FKBP dissociation in live
cells, it could be argued that protein turnover would have
appeared as a decline in luciferase activity—that is, as a
subpopulation of rapamycin-FKBP-FRB complexes degraded
in the presence of excess FK506, newly synthesized proteins
could have been blocked by FK506 from forming FRB-FKBP
complexes. However, cycloheximide data indicated that this
was not the case. Last, a completely independent readout was
used to assess complementation on a faster time scale. Building
on our previously published studies on bioluminescense sensing
of EGFR protein conformation changes induced by EGF (Yang
et al., 2009), complementation reversibility was apparent from
the rapid biphasic response of the CBG luciferase PCA sensor.
When taken together, these data supported the rapid reversibiliy
of our luciferase PCA pairs.
The considerable variation in spectral emission of the novel
luciferase constructs described in this study may allow for the
interrogation of different proteins of interest tagged with various
luciferase fragments. Because of the differences in color, the
signals can be quantified and followed in real time, thereby
expanding the repertoire of useful information derived from
cotransfected cells using one luciferase substrate (D-luciferin).
The luciferase PCA systems described here allow at least
twodifferentmethods ofmeasuringmultiple interactions simulta-
neously. First, because protein interactions that force proximity
of incompatible fragments of firefly luciferase and click beetle
luciferase (e.g., FLuc-N +CBG-C or CBG-N + FLuc-C; Figure 1B)
do not emit significant amounts of light, signals from these frag-
ments will be exceedingly low when compared to the photon
flux of other matched homologous pairs. This feature, generaliz-
able from the rapamycin-induced protein interaction data
(Figure S6), allows for the simultaneous measurement of two
discrete protein interactions (A + B and X + Y) by pairing CBG-
N+CBG-CandFLuc-N+FLuc-C fusion constructs, respectively,
within the same cell (Figure S8A). Importantly, the distinct prop-
erty of the N termini of both CBG and CBR luciferases to recon-
stitute activity with the C terminus of CBG allows use of CBG-C
as the contact point for a PCA color switch in the analysis of
a multi-interaction protein network. Thus, the CBG-C fragment,
when fused to a protein that interacts with two different proteins
tagged with CBG-N and CBR-N, may enable the ratio of
competing protein complexes (A + C or B + C) to be monitored
as a color switch between states (Figure S8B). This principle of
heteroprotein fragment complementation was applied success-
fully to real-time analysis of b-TrCP (Figure 5), an E3-ligase
common to the regulation of both b-cat and IkBa, to identify
GSK3b as a novel candidate kinase regulating IkBa processing.
This was supported by pharmacological andmutational analysis.
Using the complementation fragment sites identified in our
original incremental truncation screen with FLuc (Luker et al.,
2004), a recent report generated analogous N- and C-terminal
fragments of Brazilian C. distinctus luciferase (Emerald Luc,
ELuc(1–413; 394–542) and CBR(1–414; 395–542) as PCA
reporters (Hida et al., 2009). Further mutagenesis of the
C-terminal fragment of CBR identified a mutant CBR-C(F420I,
G421A, E453S; termed McLuc1) that performed similarly to our
CBG-C in its ability to complement productively with both
CBR-N (red) and ELuc-N (green). However, unlike our CBG-C,1026 Chemistry & Biology 17, 1018–1029, September 24, 2010 ª201McLuc1 could also complement with FLuc-N (red). Signals
12-fold and 40-fold over native FLuc and ELuc PCA systems,
respectively, as well as strong inducibility and reversibility were
reported. However, all quantitative analysis in the report were
from lysates (Promega reagent) measured in a luminometer
rather than real-time live cell imaging in an IVIS, as described
in the present report. Although analysis of lysates traverses
membrane permeability issues with compounds such as rapa-
mycin and FK-506, commercial luminescence reagents contain
signal enhancers and stabilizers not found in living cells. Thus,
in addition to the use of different cell types, the results are diffi-
cult to compare quantitatively. Nonetheless, both McLuc1 and
CBG-C would appear to afford robust multicolor luminescent
PCA systems. Thus,multicolor luciferase heteroprotein fragment
complementation systems may prove useful for assessing
multiprotein interactions in live cells in real time. The CBR/CBG
systemmay also enable imaging within the physiological context
of animals in vivo (Figure S9).
Because the CBR/CBG constructs provide convenient cloning
sites, the platforms illustrated herein could generalize to a broad
array of protein interaction complexes. Heteroprotein fragment
complementation using a single bioluminescence substrate
provides a promising tool for high-throughput screening, direct
and indirect quantification of drug and ligand binding to specific
protein complexes, and the noninvasive characterization of
mechanisms of therapeutic response. This strategy may permit
real-time examination of reversible protein interaction switches
previously difficult to kinetically discern in living organisms.SIGNIFICANCE
Full understandingof the functional complexity of theprotein
interactome requires mapping of biomolecular complexes
within the cellular environment over biologically relevant
time scales. Herein, we described a set of reversible, multi-
colored heteroprotein fragment complementation systems
based on various firefly and click beetle luciferases that
utilize the same substrate, D-luciferin. Compared to fluores-
cent proteins, luciferase strategies provide minimal or no
background activity, reversibility, and excitation-free read-
outs. The click beetle green luciferase complementation
fragments provide an effective protein complementation
system for the measurement of single protein interaction
pairs, while mixed click beetle red and green luciferase frag-
ments enable simultaneous dual-color quantification of two
discrete pairs of interacting proteins simultaneously or two
distinct proteins interacting with a third shared protein.
These multicolored heteroprotein fragment complementa-
tion systems may allow for more stringent analysis and
detailedstudyofmultiprotein interactions, provideastrategy
for higher order high-throughput screens, andhelpdeconvo-
lute interaction schemes in real time within living cells.EXPERIMENTAL PROCEDURES
Plasmids
Click beetle luciferase (Pyrophorus plagiophthalamus) complementation frag-
ments were generated using the plasmids pCBG99 and pCBR (Promega).
PCRwas performed on pCBG99 and pCBR to introduce convenient restriction0 Elsevier Ltd All rights reserved
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Multicolor Click Beetle Luciferase Complementationsites (BsiWI 50 and XhoI 30) for direct insertion of pCBG99 or pCBR open
reading frames into our previously described firefly luciferase complementa-
tion fragment constructs (Luker et al., 2004). The amino acid sequences
expressed by the click beetle inserts corresponded to 2–413 for the
N-terminus and 395–542 for the C terminus. The primers used were as follows:
forward primer for pCBR-N: AGAGCGTACGCGTCCCGGGGCGGTGGCTCAT
CTGGCGGAGGTGTAAAGCGTGAGAAAAATGTCATC; forward primer for
pCBG-N: AGAGCGTACGCGTCCCGGGGCGGTGGCTCATCTGGCGGAGGT
GTGAAGCGTGAGAAAAATGTCATC; reverse primer for both click beetle
N-termini: AGAGGGATCCGCCACCATGAAGGGTTATGTCAATAACGTTGAA
GC; forward primer for both click beetle C-termini: AGAGGGATCCGCCACC
ATGAAGGGTTATGTCAATAACGTTGAAGC; reverse primer for pCBG-C: AGA
GCGTACGAGATCTGACCTCCGCCAGATGAGCCACCTCCACCGCCGGCCT
TCTCCAACAATTGTTT; reverse primer for pCBR-C: AGAGCGTACGAGATCT
GACCTCCGCCAGATGAGCCACCTCCACCGCCGGCCTTCACCAACAATTG
TTT. The PCR products were subcloned into a topoisomerase plasmid
(pZeroBlunt PCR4Blunt, Invitrogen) for sequencing and subsequently trans-
ferred using BsiWI and XhoI, or BsiWI and BamHI into pFRB-FLuc-N and
pFLuc-C-FKBP (Luker et al., 2004), respectively. All the vectors were then
transferred identically into pTriEx3Neo (Novagen) triple expression vector to
ensure equivalent expression levels in transient transfection experiments
and to minimize error.
To construct pEGFR-CBG-N, the NLuc fragment was removed from
pEGFR-NLuc (a kind gift of L. Pike, Washingtin University in St Louis) (Yang
et al., 2009) and was replaced with CBG-N from pFRB-CBG-N using BsiWI
and AvrII sites available in both plasmids. pEGFR-CBG-C was created in
two steps. First, CBG-C was amplified by PCR and cloned by replacement
of CBG-N in pFRB-CBG-N, using BsiWI and XbaI sites. The primers used in
amplification of CBG-C from pCBG-C-FKBP were as follows: forward:
GCCGCGTACGCGCAGATCGCGTCCCGGGGCGGTGGCTCATCTGGCGGA
GGTTCCGGTAAGGGTTATGTCAATAACGTTGAAGC; reverse: CGGCTCTAG
ACTAACCGCCGGCCTTCTCCA. This resulted in pFRB-CBG-C. FRB was
then removed from pFRB-CBG-C by digestion with HindIII and BsiWI and
replaced with EGFR from pEGFR-NLuc using the same enzymes.
pCBG-C-b-TrCP was constructed by PCR amplification of CBG-C from
pCBG-C-FKBP with a linker sequence (15 amino acid Gly-Ser repeats) using
the followingprimers: forwardprimerpCBG-C-bTrCP: AAGCTTGCCACCATGA
AAGGCTACGTGAACAATGTGGAGGCCAC; reverse primer pCBG-C-bTrCP:
TGCTAGCTCGAGCCACCGCTGGACCCGGATCCACCGCTAGAGCC. The
PCR product was subcloned into a topoisomerase plasmid (pZeroBlunt
PCR4Blunt) for sequencing, and then digested with EcoRI and BamHI in EcoRI
bufferwithBSA.pb-TrCP (kindgift fromPeterHowley, HarvardMedical School)
was digestedwith BamHI andNotI in BamHI buffer. Finally pcDNA3.1-V5/His A
(Invitrogen) was digested with EcoRI and NotI in EcoRI buffer with BSA. The
three fragments were ligated using T4 Rapid Ligase (Invitrogen).
pIkBa-CBR-N was created by amplifying CBR-N from pFRB-CBR-N using
the following primers: pIkBa-CBR-N forward: GGATCCGGCGGTGGCTCAT
CTGGCGGAGGT; pIkBa-CBR-N reverse: GCGGCCGCTTAGCCGTCGTCG
TCGATGGCCTCCTTG. ThePCRproductwas subcloned into a topoisomerase
plasmid (pZeroBlunt PCR4Blunt) for sequencing, digested with NotI and
BamHI, and ligated into pIkBa-FLuc (Gross and Piwnica-Worms, 2005) which
had been similarly digested.
pb-cat-CBG-Nwas similarly created from pFRB-CBG-N using the following
primers: pb-cat-CBG-N forward: GGATCCGGCGGTGGCTCATCTGGCGGA
GGT; pb-cat-CBG-N reverse: GCGGCCGCTTAGCCGTCGTCGTCGATGGC
CTCCTTG. The PCR product again was subcloned into a topoisomerase
plasmid (pZeroBlunt PCR4Blunt) for sequencing, digested with ApaI and
BamHI, and ligated into pb-cat-FLuc (Naik and Piwnica-Worms, 2007) which
had been similarly digested.
pkB5-IkBa-FLuc, the transcriptionally coupled IkBa-firefly luciferase fusion
reporter, has been described (Moss et al., 2008). Plasmids expressing the
IkBa S32A and S36A mutants, singly or together, were prepared by Quik-
change mutagenesis (Stratagene, San Diego, CA, USA) following the protocol
provided by the manufacturer. pNFkB-Luc was purchased from Stratagene.
Luciferase PCA Imaging In Cellulo
HEK293T cells (13 104 per well of a 96-well plate) were transfected with a total
of 155 ng of DNA (75 ng of each PCA fusion construct plus 5 ng RenillaChemistry & Biology 17, 1018–102luciferase [pRlucN1, Biosignal Packard] for normalization of transfection effi-
ciency and plating uniformity) using 3 ml Fugene6 (Roche Applied Sciences)
for each 1 mg DNA in batch transfections. After 48 hr in Dulbecco’s Modified
Eagle’s Medium (DMEM) (GIBCO/BRL, Bethesda, MD) with 10% DFBS and
1% glutamine (Sigma-Aldrich), 100 nM rapamycin or vehicle was added to
wells and incubated in media for 6 hr. The cells were then washed with PBS
and imaged in colorless MEBSS (Modified Earle’s balanced salt solution:
144 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 0.8 mM NaH2PO4, 1.2 mM
CaCl2, glucose 5.6 mM, and HEPES 4 mM [pH 7.4]) containing 1% heat-inac-
tivated fetal bovine serum (DFBS) (HyClone) and 150 mg/ml D-luciferin (Bio-
synth). Live cells were imaged with a cooled charge-coupled device (CCD)
camera in a light-tight box (Caliper Lifesciences, IVIS 100) at 37C using
open, 540AF20 band pass, and 590 long pass or 650A long pass filters in rapid
succession to image all light, green light and red light, respectively (f-stop, 1;
FOV, 20 cm; binning, 4; exposure time, varies from 10 s to 5 min depending
on transfection efficiency and total photon output). For RLuc imaging, D-lucif-
erin-containing solution was replaced with colorless MEBSS supplemented
with 1% DFBS and 1 mg/ml coelenterazine (Biotium Inc.). Acquisition parame-
ters were f/stop, 1; FOV, 15 cm; binning, 4; exposure time, 10 s; and < 510
filter. Data were analyzed using LivingImage (Caliper) and Igor (WaveMetric)
analysis software packages and presented as photon flux (photons/sec)
without or with normalization to initial (t = 0) values (fold-initial).
Detailed methods for determination of drug titration curves, reversibility of
PCA systems, EGFR protein conformation sensing, D-luciferin concentra-
tion-dependence, and spectral deconvolution in cellulo as well as biolumines-
cence imaging of PCA systems in mice in vivo are described in Supplemental
Experimental Procedures.Imaging a Two-Color PCA Protein Interaction Switch In Cellulo
HEK293T cells (13 104 per well of a 96-well plate) were batch transfected with
pIkBa-CBR-N, pb-cat-CBG-N, pCBG-C-b-TrCP in ratios of 1:9:10, respec-
tively, at a total DNA of 155 ng (7.5 ng, 67.5 ng, and 75 ng, respectively) using
3 ml Fugene6 for each 1 mg DNA. Empty vector (pTriEx3Neo) was used as
a control to replace either pIkBa-CBR-N or pb-cat-CBG-N in the aforemen-
tioned proportions when isolating one protein interaction. After 48 hr, cells
were washed with PBS, MEBSS containing 10%DFBS, 1% glutamine, and
150 mg/ml D-luciferin was added, and cells allowed to equilibrate at 37C for
15 min within the IVIS 100 imaging instrument. Imaging sequences were
performed immediately upon addition of concentrated ligand (TNFa, final
concentration 20 ng/ml) and/or drug (GSK3b inhibitor SB-216763; Frame
and Cohen, 2001; final concentration 50 mM) or vehicle (DMSO, 1 ml/ml) in pre-
warmed MEBSS imaging buffer. Live cells were imaged at 37C using open,
540AF20 band pass, and 650A long pass filters in rapid succession to image
all light, green light and red light, respectively (f-stop, 1; FOV, 20 cm; binning,
4; exposure time, 1 min for each filter taken in succession for 35 min). Data
were analyzed using LivingImage and Igor analysis software packages.
Images were then spectrally unmixed using the Biolumunmix v.1.0 software
plug-in on ImageJ (Gammon et al., 2006) and data normalized to time t = 0
(fold-initial), and untreated cells (fold-untreated).Imaging NFkB-Dependent Transcription and IkBa Processing
In Cellulo
For NFkB-dependent transcriptional analysis, HEK293T cells were transfected
with pNFkB-Luc (200 ng/well) in a black 24-well plate using Fugene6 reagent,
and 48 hr after transfection, media was replaced with DMEM imaging media.
A pretreatment image was obtained after a 15 min pre-equilibration period in
the IVIS imaging system, following which cells were treated with TNFa (final
concentration 20 ng/ml) and/or drug (GSK3b inhibitor SB-216763, final
concentration 50 mM) or vehicle control (DMSO). After 2 hr of incubation in
a humidified 5% CO2 incubator, a posttreatment image was acquired.
For analysis of IkBa processing, QuikChange Site-Directed Mutagenesis
(Stratagene) was utilized to mutate IkBa at Ser-32, Ser-36, or both to Ala in
the pkB5-IkBa-FLuc plasmid (Moss et al., 2008). Fugene6 (Roche) was
used to transiently transfect HepG2 cells with wild-type and mutant reporters.
After 48 hr, media was replaced with fresh media containing D-luciferin, cells
were stimulated with TNFa (20 ng/mL) or vehicle, and imaging was performed
in an IVIS 100 under 5% CO2 as above. Photon flux data were analyzed and9, September 24, 2010 ª2010 Elsevier Ltd All rights reserved 1027
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software packages.
Western Blot Analysis
For analysis of luciferase PCA fusions, HEK293T cells were batch transfected
with 20 mg total of appropriate mixtures of plasmids expressing luciferase PCA
fusions and pRlucN1 in 10 cm dishes so as to be confluent within 48 hr.
Aliquots of the batch transfections were also plated into a 96-well plate to vali-
date expression and inducibility; 48 hr after transfection, the cells in the 96-well
plate were imaged with or without addition of rapamycin to measure fold-
inducibility (luciferase PCA fusions) and confirm equal transfection (RLuc) as
above, whereas the cells in the 10 cm dishes were washed with 10 ml of
cold PBS, then lysed for 15 min using 1 ml of reporter lysis buffer (Promega)
and scraped. Lysates were spun at 14,000 rpm, and the supernatant was
removed and frozen at 80C. Thawed samples (50 mg of protein by Biorad
Protein Assay per well) were separated by 12% SDS-PAGE and transferred
to PVDFmembranes.Membraneswere blocked in 5%milk/TBS-T and probed
overnight at 4C with a 1:500 dilution of a primary rabbit anti-click beetle lucif-
erase antiserum (Supplemental Experimental Procedures). Membranes were
washed 3 3 10 min and incubated with 1:1000 dilution of goat anti-rabbit
secondary antibody conjugated to horseradish peroxidase (AmershamBiosci-
ence). In related western blot analysis, specimens were similarly probed for all
luciferase fragments using rabbit polyclonal antibody reactive to FRB (H-266;
Santa Cruz Biotechnology) at 1:100 dilution and goat polyclonal antibody to
FKBP (N-19; Santa Cruz Biotechnology) at 1:100 dilution, and then were incu-
bated with anti-rabbit secondary antibody conjugated to horseradish peroxi-
dase (HRP) (GE Healthcare) for FRB blotting at 1:1000 dilution and anti-goat
secondary antibody conjugated to HRP (Jackson ImmunoResearch Laborato-
ries) at 1:2,000 dilution. Control blots confirmed the absence of specific bands
in mock transfected cells. A nonspecific band at 55 kD confirmed equal
loading of lanes. Images were resolved with luminol reagent (Amersham) in
an IVIS 100 instrument and analyzed using LivingImage and Igor software.
For comparison of endogenous and PCA fusion protein levels, HEK293T
cells were transfected in 6-well dishes with various combinations of pIkBa-
CBR-N, pb-cat-CBG-N, and pCBG-C-b-TrCP for 48 hr, followed by treatment
with SB216763 (50mM) and TNFa (20 ng/mL) for 30 min. Western blot analysis
was performed as above following 10%SDS-PAGE. Antibodies to b-cat, IkBa,
and b-TrCP (Santa Cruz Biotechnology, sc-7199, sc-203, and sc-15354,
respectively) were used at 1:1000 dilutions for b-cat and IkBa, and 1:200 for
b-TrCP. All secondary antibodies were used at 1:1000 dilutions for visualiza-
tion of proteins. Blots were then stripped and reprobed using an antibody to
actin (Sigma-Aldrich) to validate equal loading. Untransfected and cross-
transfected samples as well as electrophoretic mobility confirmed the identity
of endogenous proteins (data not shown).SUPPLEMENTAL INFORMATION
Supplemental Information includes nine figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.chembiol.2010.06.018.
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